Fig. 2From: Different dosage regimens of Eptinezumab for the treatment of migraine: a meta-analysis from randomized controlled trialsThe pooled standard mean difference (SMD) of monthly migraine days (MMDs) in different treatment doses compared with placebo, the diamond indicates the estimated SMD with 95% confidence interval (CI) for the pooled patientsBack to article page